Is PGT-P cutting edge or should we cut it out?

PGT for polygenic risk scoring (PGT-P) is a novel screening strategy of embryos for polygenic conditions and traits. With several companies now offering PGT-P, the clinical utility and ethics of polygenic risk scoring are being hotly debated. Join us live from the ASRM Annual Meeting as we debate the role of PGT-P in modern REI practice. We will be joined by a team of clinical and scientific experts to unpack both sides of the argument and hopefully arrive at a consensus.

Moderators: 

Eve Feinberg, MD

Pietro Bortoletto, MD

Speakers:
Marja Brolinson, MD
Nathan Treff, PhD, HCLD
Lee Shulman, MD
Ginny Ryan, MD